Sight Sciences (SGHT) Preferred Shares (2020 - 2021)
Sight Sciences' (SGHT) quarterly Preferred Shares came in at $22.2 million in Q2 2021, little changed quarter-over-quarter from $22.2 million in Q4 2020.
Sight Sciences (SGHT) Preferred Shares (2020 - 2021) Analysis & Trends
Sight Sciences' Preferred Shares history runs 2 years deep, the most recent figure standing at $22.2 million for Q2 2021.
- On a quarterly basis, Preferred Shares changed N/A year-over-year to $22.2 million in Q2 2021; TTM through Jun 2021 was $22.2 million, a N/A change from a year earlier, with the FY2020 full-year figure at $22.2 million, changed N/A from the prior year.
- Preferred Shares held at $22.2 million in Q2 2021 per SGHT's latest filing, from $22.2 million in the prior quarter.
- Across five years, Preferred Shares topped out at $22.2 million in Q4 2020 and bottomed at $22.2 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | - |
| 10 | Sight Sciences | 274.03 Mn | 189.07 Mn | 16.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 22.23 Mn |
| Dec 31, 2020 | 22.23 Mn |